Modelled DT Structure
Method: homology modeling
Template PDB: 5UJ9_A
Identity: 31.587%
Minimized Score: -1310.131 kcal/mol
Detail: Structure Info
Drug Transporter (DT) Information
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0057 | ||||
| Gene Name | ABCC11 | ||||
| Protein Name | Multidrug resistance-associated protein 8 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
|
||||
| Synonyms | ABCC11; ATP-binding cassette sub-family C member 11; EWWD; MRP8; WW | ||||
| DT Family | ATP-Binding Cassette (ABC) Superfamily | ||||
| Drug Conjugate Transporter (DCT) Family (ABCC) | |||||
| Tissue Specificity | Expressed in ceruminous apocrine gland (atprotein level) (PubMed:19383836, PubMed:19710689). Expressed inmany tissues. Not expressed in kidney, spleen and colon. Highlyexpressed in breast cancer. Expressed at moderate levels in normalbreast and testis and at very low levels in liver, brain andplacenta. | ||||
| Function | This transporter plays a key function in the secretion of odorants and their precursors from apocrine sweat glands. | ||||
| Disease(s) | Leukemia [ICD-11: 2A60-2B33] | ||||
| Hypercalcemia [ICD-11: 5B91.0] | |||||
| Endogenous Substrate(s) | Cyclic nucleotides; Nucleoside analogues; Nucleotide analogues; Fluoropyrimidines | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
(ε) Exogenous Modulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(γ) Outward/inward-facing Conformation |
|||||
|
(δ) Xenobiotics-regulated Structural Variability |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
| Molecular Transporting Profile of This DT | |||||
|
Full List of Drug(s) Transported by This DT |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 4 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
|
Methotrexate
|
Approved | Drug Info | Leukemia | 2A60-2B33 | [1] |
|
Prasterone
|
Approved | Drug Info | Hypercalcemia | 5B91.0 | [2] |
|
Tenofovir
|
Approved | Drug Info | Human immunodeficiency virus infection | 1C62.Z | [3] |
|
Zalcitabine
|
Approved | Drug Info | Human immunodeficiency virus infection | 1C62.Z | [4] |
|
Endogenous Metabolites (EMs) Handled by This DT |
|||||
|
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 1 EMs in Total | ||||
| EM Name | PubChem CID | Detail | Experimental Material | Ref | |
| Leukotriene C4 | EM Info | Unclear experiment used for identifying this EM | [5] | ||
|
Drug-DT Affinity Assessed by Cell Line |
|||||
|
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
| Drug Name | Highest Status | Detail | Cell Line | Affinity | Ref |
| Methotrexate | Approved | Drug Info | LLC-PK1 cells-MRP8 | Km = 957 microM | [6] |
| References | |||||
| 1 | ABCC11/MRP8 confers pemetrexed resistance in lung cancer. Cancer Sci. 2010 Nov;101(11):2404-10. | ||||
| 2 | Human multidrug resistance protein 8 (MRP8/ABCC11), an apical efflux pump for steroid sulfates, is an axonal protein of the CNS and peripheral nervous system. Neuroscience. 2006;137(4):1247-57. | ||||
| 3 | Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11. Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e01725-16. | ||||
| 4 | MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine. J Biol Chem. 2003 Aug 8;278(32):29509-14. | ||||
| 5 | Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development. Curr Med Chem. 2008;15(20):1981-2039. | ||||
| 6 | Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol. 2005 Feb;67(2):545-57. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.